Fiziomed - Company finances
|
EUR
|
2020
From: 2020-01-10
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 9,824 | 19,210 | 21,860 | 7,530 | 21,580 | 29,965 |
| Profit before tax | 3,845 | 8,388 | 6,704 | -7,472 | 5,574 | 4,248 |
| Net profit | 3,845 | 7,964 | 6,369 | -7,472 | 5,574 | 4,106 |
| Equity | 3,945 | 11,909 | 18,278 | 10,806 | 16,380 | 20,486 |
| Liabilities | 600 | 494 | 1,055 | 0 | 25,882 | 16,105 |
| Non-current assets | 0 | 9,328 | 13,258 | 8,620 | 33,374 | 23,971 |
| Current assets | 4,512 | 3,029 | 6,005 | 2,172 | 8,753 | 12,458 |
| Total assets | 4,512 | 12,357 | 19,263 | 10,792 | 42,127 | 36,429 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 511 | 78 | - |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +95.5% | +13.8% | -65.6% | +186.6% | +38.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 85.2% | 64.4% | 33.1% | -69.2% | 13.2% | 11.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 97.5% | 66.9% | 34.8% | -69.1% | 34.0% | 20.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 39.1% | 41.5% | 29.1% | -99.2% | 25.8% | 13.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 39.1% | 43.7% | 30.7% | -99.2% | 25.8% | 14.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.0 | 0.1 | - | 1.6 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Fiziomed - Social security debts
The amount of overdue SODRA debt for the company Fiziomed as of the last working day is: 0 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-26 | 2026-09-27 | 0.43 |
| 2026-09-20 | 2026-09-21 | 0.43 |
| 2026-09-05 | 2026-09-17 | 0.43 |
| 2026-09-01 | 2026-09-02 | 0.43 |
Fiziomed - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Fiziomed, MB (code 305425951) is a Small partnership engaged in physiotherapy activities. In 2025, the company generated revenue of €30.0K and net profit of €4.1K, compared with €21.6K revenue and €5.6K net profit in 2024. This follows a sharp improvement from 2023, when revenue was €7.5K and the company recorded a net loss of €7.5K. Over the latest three years, revenue has therefore risen steadily, while profitability moved from a loss to positive earnings, although the 2025 profit margin of 13.7% was below the 2024 level of 25.8%. The 2-year revenue growth rate stood at +297.9%, and year-on-year revenue growth in 2025 was +38.9%. At the end of 2025, total assets amounted to €36.4K, equity to €20.5K and liabilities to €16.1K. The equity ratio was 56.2%, debt-to-equity 0.79, ROE 20.0% and ROA 11.3%. Asset turnover was 0.82x, indicating moderate use of assets to generate revenue.